I now have comprehensive information from multiple authoritative textbooks. Here is a full, well-structured answer:
Erythropoiesis
Erythropoiesis is the process by which red blood cells (erythrocytes) are produced and maintained in the circulation. Under normal conditions, roughly 1% of circulating erythrocytes is replaced daily - about 250 billion cells, or 2.5-3 million erythrocytes per second.
- Brenner and Rector's The Kidney, p. 2465
- Histology: A Text and Atlas, p. 746
Sites of Production
- Fetus/newborn: liver, spleen, yolk sac (primitive erythropoiesis)
- Children: bone marrow of most bones
- Adults: axial skeleton (vertebrae, sternum, pelvis, proximal long bones)
Cell Lineage - From Stem Cell to Mature RBC
The erythroid pathway proceeds stepwise through the bone marrow:
| Stage | Key Features |
|---|
| Pluripotent stem cell | Self-renewing; gives rise to all blood lines |
| CFU-GEMM | Mixed myeloid progenitor (granulocyte, erythroid, monocyte, megakaryocyte) |
| BFU-E (burst-forming unit - erythroid) | Early committed erythroid progenitor; EPO-responsive |
| CFU-E (colony-forming unit - erythroid) | Highly EPO-sensitive; commits fully to red cell lineage |
| Proerythroblast | First morphologically recognizable RBC precursor; large cell, basophilic cytoplasm, prominent nucleoli, no hemoglobin yet |
| Basophilic erythroblast | Smaller; strong cytoplasmic basophilia from ribosomes actively synthesizing hemoglobin |
| Polychromatophilic erythroblast | Hemoglobin accumulates; cytoplasm shifts from blue-gray to more eosinophilic; last stage where mitosis occurs |
| Orthochromatic erythroblast (Normoblast) | Extremely condensed, small nucleus; nearly full hemoglobin load; incapable of further division |
| Reticulocyte | Nucleus extruded; still contains ribosomes and mRNA capable of hemoglobin synthesis; released from bone marrow; circulates 1-2 days before maturing in spleen |
| Mature erythrocyte | Biconcave disc; no nucleus or organelles; lifespan ~120 days |
Each normoblast undergoes 4 more cell divisions after formation, with progressive nuclear condensation at each step. The whole process from basophilic erythroblast to circulation takes approximately one week.
- Basic Medical Biochemistry, p. 1536
- Histology: A Text and Atlas, pp. 775-777
Regulation - The EPO Feedback Loop
Fig. Erythropoietin stimulation of erythrocyte maturation - Basic Medical Biochemistry, p. 1536
Control of red cell mass operates through a classic negative feedback loop:
- Oxygen sensor: Peritubular fibroblasts in the renal cortex detect reduced oxygen delivery (hypoxia, anemia, blood loss)
- EPO release: These cells upregulate production of erythropoietin (EPO) - a 30.4 kDa glycoprotein
- Bone marrow stimulation: EPO binds EPO receptors (EPO-Rs) on erythroid progenitors (particularly CFU-E and BFU-E), driving proliferation and maturation
- Rising RBC mass: As RBC numbers increase, oxygen delivery improves, shutting off EPO production
EPO rises within 24-48 hours of a hypoxic stimulus and declines over ~3 weeks as hematocrit normalizes.
Required cofactors
For erythropoiesis to proceed normally, several cofactors must be available:
- Iron - for heme synthesis
- Vitamin B12 - for DNA synthesis (nuclear maturation)
- Folate - for DNA synthesis
- Intrinsic factor - for B12 absorption
Deficiency of any of these causes distinct anemias (iron-deficiency anemia, megaloblastic anemia, etc.).
- Brenner and Rector's The Kidney, pp. 2465-2466
RBC Life Cycle Completion
After ~120 days, senescent erythrocytes are phagocytosed by macrophages in the spleen, bone marrow, and liver. The breakdown products are recycled:
-
Globin → hydrolyzed to amino acids → metabolic pool
-
Iron → stored as ferritin/hemosiderin in spleen → reused for hemoglobin synthesis
-
Heme ring → converted to bilirubin → bound to albumin → transported to liver → conjugated → excreted in bile
-
Histology: A Text and Atlas, p. 746
Clinical Relevance
| Condition | Mechanism |
|---|
| Renal anemia | Damaged kidneys produce insufficient EPO |
| Polycythemia vera | Dysregulation at the hematopoietic stem cell level; EPO-independent proliferation |
| High-altitude erythrocytosis | Sustained hypoxia → elevated EPO → increased RBC mass; hematocrit >60% impairs oxygen delivery via hyperviscosity |
| Iron-deficiency anemia | Insufficient iron for hemoglobin synthesis |
| Megaloblastic anemia | B12/folate deficiency impairs DNA synthesis; large, immature RBCs |
| Erythropoiesis-stimulating agents (ESAs) | Recombinant EPO used in renal anemia and chemotherapy-related anemia |